PREDICTION OF INDIVIDUAL SENSITIVITY FOR CHEMOTHERAPY

  • L. A. Syvak National cancer institute (Kyiv, Ukraine)
  • S. A. Lyalkin National cancer institute (Kyiv, Ukraine)
  • T. Ye. Tarasenko National cancer institute (Kyiv, Ukraine)
  • N. V. Kasap National cancer institute (Kyiv, Ukraine)
  • M. Y. Klimanov National cancer institute (Kyiv, Ukraine)
  • N. N. Maydanevich National cancer institute (Kyiv, Ukraine)
  • A. V. Askolsky National cancer institute (Kyiv, Ukraine)
  • N. O. Verovkina National cancer institute (Kyiv, Ukraine)
Keywords: oncology, chemotherapy, chemosensitivity.

Abstract

The study of individual sensitivity to chemotherapy drugs is aimed at providing treatment with the most effective schemes that will not only prolong the life of patients with cancer, but also improve its quality and eliminate unwanted toxicity.

Downloads

Download data is not yet available.

References

1. Kurilyak O. A. Mikrotetrazolievyj test v prognozirovanii himiochuvstvitel'nosti karcinom yaichnikov cheloveka (eksperimental'noe issledovanie): Avtoref. dis. ... kand. biol. nauk. – M., 1993. – 24 s.
2. Bin Wu, Zhu J. S., Zhang Y. et al. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: One institution’s experience // World J. Gastroenterology. – 2008. – Vol. 14, N 19. – Р. 3064–3068.
3. Burstein H. J. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays // J. Clin. Oncology. – 2011. – Vol. 29, N 24. – Р. 3328–3330.
4. Han S. S., Choi S. H, Lee Y. K. et al. Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer // Cancer Invest. – 2008. – Vol. 26, N 4. – Р. 426–430.
5. Hur H., Kim N. K.,* Kim H. G. et al. Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis // Br. J. Сancer. – 2012. – Vol. 106, N 1. – Р. 53–60.
6. Jung P. S. Kim D. Y., Kim M. B. et al. Progression-free survival is accurately predicted in patients treated with chemotherapy for epithelial ovariancancer by the histoculture drug response assay in a prospective correlative clinical trial at a single institution // Ant. Research. – 2013. – Vol. 33, N 3. – Р. 1029–1034.
7. Kato R., Hasegawa K., Achiwa Y. et al. Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay // Eur. J. Gynaecology Oncology. – 2011. – Vol. 32, N 4. – Р. 381–386.
8. Kern D. H., Mizuno Y., Hashimura T. et al. Comparison of drug sensitivity among tumor cells within a tumor between primary and metastases, and between different metastases in the human tumor colony-forming assay // Cancer Research. – 1984. – Vol. 44. – Р. 2309–2312.
9. Kim H. A., Yom C. K., Moon B. I. et al. The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer // Breast. – 2008. – Vol. 17, N 1. – Р. 19–26.
10. Kurbacher C. M., Grecu O. M., Stier U. еt al. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials // Recent Results Cancer Res. – 2003. – Vol. 161. – Р. 221–230.
11. Michalski C. W., Erkan M., Sauliunaite D. et al. Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer // Br. J. Cancer. – 2008. – Vol. 99, N 5. – Р. 760–767.
12. Moon Y.W., Kim S. W., Nam E. J. et al. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer // Cancer. – 2007. – Vol. 109, N 9. – Р. 1829–1835.
13. Mueller H., Kassack M. U., Wiese M. Comparison of the usefulness of the MTT, ATP and Calcein Assays to predict the potency of cytotoxic agents in various human cancer cell lines // J. Biomolecular Screening. – 2004. – Vol. 9, N 6. – Р. 2004.
14. Park Yu., Kim Y. S., Bang S. et al. In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Gastric Cancer // J. Gastric. Cancer. – 2010. – Vol. 10, N 4. – Р. 155–161.
15. Phillips R. M., Bibby M. C., Double, J. A. A Critical Appraisal of Predictive Value of in Vitro ChemosensitivityAssays // JNCI. – 1990. – Vol. 82. – Р. 1457–1468.
16. Schinköthe T., Thiruchittampalam D., Schmidt A. et al. The AutoDiSC: development and validation of a novel chemotherapy sensitivity and resistance assay // An. Res. – 2013. – Vol. 33, N 6. – Р. 2491–2498.
17. Susan Jenks Chemosensitivity Assays: Still Eyeing the Clinic // J. Natl. Cancer Inst. – 2012. – Vol. 104 (Іss. 23). – P. 1775–1777.
18. Uruno T., Masaki Ch., Akaishi Ju. et al. Chemosensitivity of anaplastic thyroid cancer based on a histoculture drug response assay // Int. J. Endocrinology. – 2015. – Vol. 967. – Р. 286.
19. Xu J. M., Song S. T., Tang Z. M. et al. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro // Br. Сancer Res. Treatment. – 1999. – Vol. 53, N 1. – Р. 77–85.
20. Yongzhuang Su. Cancer сhemosensitivity testing: review // J. Cancer Therapy. – 2014. – Vol. 5. – Р. 672–679.
21. Yoshimasu T., Oura S., Hirai I. et al. Data acquisition for the histoculture drug response assay in lung cancer // J. Thoracic Сardiovascular Surgery. – 2007. – Vol. 133, N 2. – Р. 303–308.

Abstract views: 180
PDF Downloads: 191
Published
2018-12-30
How to Cite
Syvak, L. A., Lyalkin, S. A., Tarasenko, T. Y., Kasap, N. V., Klimanov, M. Y., Maydanevich, N. N., Askolsky, A. V., & Verovkina, N. O. (2018). PREDICTION OF INDIVIDUAL SENSITIVITY FOR CHEMOTHERAPY. Likars’ka Sprava, (7-8), 61-66. https://doi.org/10.31640/JVD.7-8.2018(10)
Section
Original investigations